This research service focuses on the Malaysian healthcare industry, providing a detailed overview of the investment scenario in particular. A brief overview of the tendering process, incentives for investors, and the distributor network has also been included.
This study does broadly discuss the revenue or financial forecasting of the healthcare industry, but does not address the companies which are involved with R&D or services in details.
Company profiles of those companies that are currently or imminently prominent and or may be of interest for investors in Malaysia, have been included.
The information contained in this research service was derived from published sources including the following—Government of Malaysia websites, healthcare companies’ websites, World Health Organization data, World Bank data, International Monetary Fund data and press releases, public sources, the internal data bank of Frost & Sullivan, and industry key opinion leaders (KOLs). Primary and secondary research methodologies were used to gather and analyze the data, presented in this study.
About this report
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores opportunities for new investors and segregates Malaysia into potential, growing and nascent market, after taking into consideration past investment, policies, trends of new investment and other growth factors (socio-economy, technology, etc). The study will give insights to investors who plan to enter the Malaysian market, as well as help the existing manufacturers to look understand the competition.
Electronic Access - Site License Fulfilled by Publisher
Electronic Access - Global site License Fulfilled By Publisher